NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
复制标题
DOI：
10.6004/jnccn.2017.0044
复制
发表时间：
2017-04-01
影响因子：
13.4
通讯作者：
Kumar, Rashmi
中科院分区：
文献类型：
--
作者：
Gradishar, William J.;Anderson, Benjamin O.;Kumar, Rashmi
这些NCCN指南见解强调了1.2017版NCCN乳腺癌指南中对激素受体阳性疾病的手术腋窝分期，放射治疗和全身治疗建议的重要更新/变化。本报告总结了这些更新，并讨论了其背后的理由。关于新药批准的更新，在记者发稿时还没有，可以在NCCN.org上找到这些指南的最新版本。
These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.